Study Stopped
The results obtained 1 year after surgery were clearly indicative of the outcome and the investigators decided to terminate follow-up at that point.
MINIMALLY INVASIVE SURGERY in Total Knee Arthroplasty
MIS GEN II
A Prospective (Non)-Randomized Controlled Multicenter Clinical Study Of the Genesis ii Total Knee System in Minimally Invasive Total Knee Arthroplasty
1 other identifier
interventional
N/A
1 country
1
Brief Summary
Overall study design: A prospective, randomized, multi-center clinical studies comparing the minimal invasive and the standard surgical total knee replacement technique (control) using the Genesis II total knee system. The study will collect efficacy, safety and socio-economical data over 2 years. An additional 5 years follow-up interval is optional. The objectives (short-term follow-up) of the study are to:
- 1.Assess whether the improvement in Pain and Range of motion per Knee Society scoring system and VAS score.
- 2.Assess whether there are any differences between the surgical techniques as regards complication rate.
- 3.Assess whether the hospital stay and the rehabilitation time (Straight leg raise, Active/passive ROM) of the patients differs between the two techniques.
- 4.Assess the x-ray mechanical alignment between the two techniques.
- 5.Improvement in Pain and Function per Knee Society Scoring system
- 6.Number and Extent of Radiographic Lucencies \>2mm
- 7.Revision and knee-related adverse events
- 8.Improvement in Quality-of-life via the VAS score
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Oct 2004
Typical duration for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2004
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2007
CompletedFirst Submitted
Initial submission to the registry
February 27, 2009
CompletedFirst Posted
Study publicly available on registry
March 2, 2009
CompletedMay 23, 2014
May 1, 2014
3 years
February 27, 2009
May 22, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain and Range of Motion on the short term as efficacy measurements. Occurence of Adverse Events as safety measurements
1 year
Secondary Outcomes (1)
Occurence of Adverse Events and Radiolucent lines > 2mm Range of motion on the mid term
2 years
Study Arms (2)
Minimal Invasive Surgery,
EXPERIMENTALStandard Surgical Technique
ACTIVE COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- require primary uni- or bilateral total knee arthroplasty; available for 2 year follow up; provide informed consent; is in stable health for cardio-pulmonary conditions.
You may not qualify if:
- inefficient femoral or tibial bone stock; BMI \>35; fixed flexion deformity \>15 degrees; knee flexion of \<90 degrees; varus/valgus deformity \>20 degrees; active local infection; conditions that would compromise the 2 years follow up.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Orthopaedic Department, University Hospital
Tübingen, 72076, Germany
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
February 27, 2009
First Posted
March 2, 2009
Study Start
October 1, 2004
Primary Completion
October 1, 2007
Study Completion
December 1, 2007
Last Updated
May 23, 2014
Record last verified: 2014-05